Mr. James J. Mauzey joined the board of directors in May 2006
and is the chairman of the compensation committee.
Mr. Mauzey has over 30 years experience in the pharmaceutical industry. He was formerly
president and chief executive officer of Bertek Pharmaceuticals, Inc, a division of Mylan Laboratories, Inc.
Prior to that, he was chief executive officer of Innovex Worldwide, the contract sales division of Quintiles Transnational Organization and chairman
and chief executive officer of Alteon Inc. In addition, Mr. Mauzey has held numerous sales, marketing and executive
positions with Lederle Laboratories and Bristol-Myers Squibb Company. Mr. Mauzey received a bachelor’s degree from Lewis University
and an MBA from Xavier University.
|